Affiliation:
1. Formulation Department, Research and Development Directorate, SIGMA Pharmaceutical Industries, Menofia, Egypt
Abstract
Nowadays, the focus has been shifted to new technologies for improving drug solubility,
permeability, and bioavailability, amid unprecedentedly increasing the number of newly discovered
Active Pharmaceutical Ingredients (APIs), which are mostly categorized under Biopharmaceutical
Classification System (BCS) as class-II and class IV. Traditional technologies and classical formulation
strategies often fail to address most of the formulation problems associated with new APIs, particularly
solubility and bioavailability. Therefore, exploring new and innovative technologies on an industrial
scale is a prerequisite and requires modernization of manufacturing processes, as well as more advanced
research and development. Liquisolid technology is a new, innovative industrial technology,
particularly designed for either improving the release rates of poorly absorbed drugs or controlling their
release pattern by achieving sustained-release profiles with zero-order release kinetics. Besides, it is a
promising photoprotective system for photosensitive drugs and can further be used for modulating the
drug microenvironmental pH. The next generation of liquisolid systems stems from a set of emerging
technologies, such as liqui-pellet technology, which originates from combining liquisolid technology
with pelletization technique, particularly extrusion-spheronization technique. This review article highlights
the current state of liquisolid technology, ongoing challenges, characterization and applications,
possible future prospects, the advent of new and emerging technologies, and the revolution of the next
generation of liquisolid technology.
Publisher
Bentham Science Publishers Ltd.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献